Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide and Dexamethasone With or Without Bortezomib in Previously Untreated Multiple Myeloma
NCT00644228Phase 3Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Jul 2008
- Primary completion
- Nov 2015
- Modality
- Small Molecules, Modified Peptides
- Countries
- 3
01
Overview
A Phase 3 trial of bortezomib in multiple myeloma (MM), sponsored by National Cancer Institute. Started Jul 2008; status: active, not recruiting.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00644228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00644228.